Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
39.6M
-
Number of holders
-
112
-
Total shares
-
35.4M
-
Shares change
-
+443K
-
Total reported value, excl. options
-
$293M
-
Value change
-
+$6.9M
-
Put/Call ratio
-
678.67
-
Number of buys
-
61
-
Number of sells
-
-50
-
Price
-
$8.29
Significant Holders of Pulmonx Corp - Common Stock (LUNG) as of Q3 2024
filings reported holding LUNG - Pulmonx Corp - Common Stock as of Q3 2024.
Pulmonx Corp - Common Stock (LUNG) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.4M shares
of 39.6M outstanding shares and own 89.35% of the company stock.
Largest 10 shareholders include FMR LLC (5.87M shares), PRIMECAP MANAGEMENT CO/CA/ (5.68M shares), MORGAN STANLEY (3.79M shares), BlackRock, Inc. (2.8M shares), VANGUARD GROUP INC (2.28M shares), DEUTSCHE BANK AG\ (1.12M shares), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (1.11M shares), JPMORGAN CHASE & CO (1.06M shares), GEODE CAPITAL MANAGEMENT, LLC (893K shares), and BRAIDWELL LP (753K shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.